A comprehensive view of Bristol-Myers Squibb Co.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
Bristol-Myers Squibb Co. Advances Cancer and Cardiovascular Treatment Options, Emphasizing Communication and Inclusion in Healthcare
Published:
May 11, 2024
by Industry Intelligence Inc.
|
Bristol Myers Squibb Provides Update on Phase 3 CheckMate -73L Trial
Published:
May 10, 2024
by Bristol-Myers Squibb Co.
|
Bristol-Myers Squibb Co. Showcases Long-Term RCC Data and Advocates for Health Equity and Rare Disease Management
Published:
May 10, 2024
by Industry Intelligence Inc.
|
Bristol-Myers Squibb Company - Submission of Matters to a Vote of Security Holders - Form 8-K
Published:
May 09, 2024
by U.S. Markets (Alternative Disclosure) via PUBT
|
BRISTOL MYERS SQUIBB CO - (8-K) - Disclosing Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
Published:
May 09, 2024
by SEC Edgar Filings
|
Ask us about our R&D/Patents market view